Pulmonary Fibrosis News

May 5, 2021May 5, 2021

IM156 on Fast Track as IPF Treatment

The U.S. Food and Drug Administration (FDA) granted fast track status to IM156, ImmunoMet Therapeutics’ treatment candidate for idiopathic pulmonary fibrosis (IPF). “Fast track designation is another important milestone for ... Read more

May 4, 2021May 4, 2021

Despite COVID Vaccinations, Caution Still Crucial for Transplant Recipients

COVID-19 News, Pulmonary Fibrosis News

Long before COVID-19 changed the world, organ transplant recipients were wearing masks to shield themselves from airborne threats. Immunosuppressive medicines, which often are a lifelong requirement after a transplant, add an ... Read more

May 3, 2021May 3, 2021

Scientists Discover New Target to Help Rejuvenate Aged Stem Cells

Pulmonary Fibrosis News

Scientists discovered that blocking a tiny RNA molecule can help rejuvenate aged mesenchymal stem cells (MSCs) — which have the ability to give rise to specialized cells — derived from ... Read more

April 30, 2021April 30, 2021

Ofev Effective in Elderly Patients, Those With Comorbidities

Pulmonary Fibrosis News

Treatment with Ofev (nintedanib) is safe and can preserve lung function in people with idiopathic pulmonary fibrosis (IPF) who are elderly or have several other health conditions, a new study ... Read more

April 28, 2021April 28, 2021

Umbilical Cord Stem Cells Hold Potential in PF Treatment

Pulmonary Fibrosis News

Small extracellular vesicles (EVs) released from umbilical cord stem cells seem to carry molecules that can inhibit the TGF-beta signaling pathway and reduce tissue damage in the lungs of mice ... Read more

April 27, 2021April 27, 2021

IPF Worsens Prognosis in Lung Cancer Patients

Pulmonary Fibrosis News

Idiopathic pulmonary fibrosis (IPF) is associated with poorer prognosis in patients with lung cancer, a study shows. People with lung cancer showed a higher risk of dying if IPF was ... Read more

April 26, 2021April 26, 2021

Chemotherapy Treats 2 With Lung Cancer Without Worsening IPF

Pulmonary Fibrosis News

Two people with idiopathic pulmonary fibrosis (IPF) and poor lung function underwent chemotherapy for small cell lung cancer (SCLC) while continuing with their antifibrotic treatment, with clinical benefit evident in ... Read more

April 23, 2021April 23, 2021

SAN903, for IPF, Significantly Lessens Fibrosis in Animal Study

Pulmonary Fibrosis News

SAN903, a candidate therapy for idiopathic pulmonary fibrosis (IPF), led to a significant reduction in markers of inflammation and fibrosis (scarring) in a mouse model of induced pulmonary fibrosis (PF), its developer, ... Read more

April 23, 2021April 23, 2021

Quick Approval Given COVID Vaccines Raise Concerns, Rare Disease Patients Say

COVID-19 News, Pulmonary Fibrosis News

More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less than willing to be vaccinated for COVID-19 if a vaccine ... Read more

April 21, 2021April 21, 2021

MUC5B Mutation May Lengthen Life for IPF Patients on Anti-fibrotics

Pulmonary Fibrosis News

A variant of the MUC5B gene, known as the rs35705950 (T) allele, appears to lead to better survival in people with idiopathic pulmonary fibrosis (IPF) on anti-fibrotic treatment, a study ... Read more

April 20, 2021April 20, 2021

United Therapeutics Asks FDA to Approve Tyvaso DPI

Pulmonary Fibrosis News

United Therapeutics has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) requesting the approval of Tyvaso DPI, an investigational dry powder inhaled formulation of ... Read more

April 19, 2021April 19, 2021

Outcomes in PF-ILD Not Due to IPF Equally Poor, Real-World Study Finds

Pulmonary Fibrosis News

Outcomes are as poor in people with progressive fibrosing interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF) as in those with IPF, according to a Japanese real-world study. ... Read more

April 16, 2021April 16, 2021

EveryLife Scholarship Fund Open Until May 7 for Adults With Rare Diseases in US

COVID-19 News, Pulmonary Fibrosis News

The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a rare disease pursue personal goals through training and education. For a ... Read more

April 16, 2021April 16, 2021

Used in Chinese Medicine, Plant Compound Reduces Lung Scarring in Rats

Pulmonary Fibrosis News

Often used in traditional Chinese medicine, a plant compound called salvianolic acid B, or SAB, has been found to reduce lung scarring (fibrosis) and blood clotting when given in an ... Read more

April 14, 2021April 14, 2021

Ofev May Help Treat IPF With Lung Cancer, Case Report Suggests

Pulmonary Fibrosis News

A patient with idiopathic pulmonary fibrosis (IPF) who also had non-small cell lung cancer responded well to treatment with Ofev (nintedanib), according to a new case report. The findings suggest ... Read more